PharmStar Pharmaceuticals CEO to Appear on The Bill Chippas Show
June 16 2011 - 9:15AM
Marketwired
PharmStar Pharmaceuticals, Inc. (PINKSHEETS: PHAR), a U.S. drug
developer, manufacturer and marketer of the FDA-approved,
Over-the-Counter (OTC) liquid pain reliever Aquaprin™, announced
today that its Chief Executive Officer, Howard Phykitt, will be
interviewed on The Bill Chippas Show on Thursday, June 16, 2011,
which airs 6:00 PM Eastern Time. Those interested in PharmStar
Pharmaceuticals are encouraged to listen live tonight at 6:20 PM ET
by visiting www.billchippasshow.com or www.Princetonresearch.com.
This will be the third interview for Mr. Phykitt on Bill's show.
Mr. Phykitt will discuss his new patent applications as they apply
to the Aquaprin technology, announced earlier this week, among
other developments with the company. Callers can talk with Mr.
Phykitt by calling 1-772-220-9788 or email questions during the
show to Bill@Billchippasshow.com.
Since 2005, Bill has hosted The Bill Chippas Show in South
Florida on AM 1590 and AM 1450. Individual investors, active
traders and institutional professionals rely on Bill's timely
unbiased analysis, deep rooted market background and experience
spanning four decades to make intelligent and common sense
investments. Bill's weekly Stock Market Comments appear in Weekly
Market Strategies delivered by Princeton Research
(www.princetonresearch.com) to global investors, and Bill's opinion
columns appear in YourNews.com. In 1996, Bill founded FuturesCom,
which remains one of today's longest running Internet-based,
independent publications for investment market research. To learn
more about Bill, visit www.billchippasshow.com.
About PharmStar Pharmaceuticals PharmStar
Pharmaceuticals, Inc. is a U.S.-based drug development,
manufacturing and marketing company and the innovator of Aquaprin™,
an FDA-approved Over-the-Counter (OTC) liquid pain reliever. In
development since 1993 with over $3 million invested to-date,
Aquaprin™ is a liquid derivative of aspirin based on a
patent-pending formula. The product is designed to dissolve nearly
instantly in just 1.5 ounces of water, which can be absorbed into
the bloodstream up to 10 times faster than traditional OTC pain
relievers, and with little to no stomach upset. PharmStar's
headquarters are located in Wilson, NC. For more information, visit
www.pharmstarinc.com.
Forward-Looking Statements Disclosure This press release
includes "forward-looking statements" within the meaning of the
federal securities laws, commonly identified by such terms as
"believes," "will," "looking ahead," "anticipates," "estimates" and
other terms with similar meaning. Although the Company believes
that the assumptions upon which its forward-looking statements are
based are reasonable, it can give no assurance that these
assumptions will prove to be correct. Important factors that could
cause actual results to differ materially from the Company's
projections and expectations are disclosed in the Company's filings
with the Securities and Exchange Commission. All forward-looking
statements in this press release are expressly qualified by such
cautionary statements and by reference to the underlying
assumptions.
Contact: PharmStar, Inc. 919-794-7000 Email Contact:
info@pharmstarinc.com www.pharmstarinc.com Investor Contact:
investors@pharmstarinc.com